A drug without a known shape
By the early 1940s penicillin was already being used clinically, but its chemical structure was unsettled: Edward Abraham had proposed a structure in 1942 containing a strained four-membered beta-lactam ring, a feature many chemists doubted could exist stably in a natural molecule. Dorothy Hodgkin’s claim, reached through X-ray crystallography and published with colleagues in 1949 after work beginning in 1945, was that the beta-lactam structure was correct — penicillin really did contain this unusual ring, against the stated expectation of much of the chemical community at the time. The claim was specifically about molecular shape: not how penicillin killed bacteria, which was worked out separately, but what the molecule actually looked like, settled by direct physical measurement rather than by argument from chemical plausibility.
Reading atoms by diffraction
Hodgkin’s method was X-ray crystallography: firing X-rays through a crystallised sample of the substance and recording the pattern the atoms inside scatter the beam into, then working backwards from that diffraction pattern to the arrangement of atoms that would produce it. This was demanding, iterative work rather than a single measurement — the same approach she had already used to publish the first structure of a steroid, cholesteryl iodide, in 1945, and would later apply over decades to vitamin B12 and to insulin. For penicillin the calculations had to distinguish between the beta-lactam structure Abraham had proposed and rival structures other chemists favoured, using the diffraction data to rule out arrangements incompatible with what was actually observed, rather than relying on which structure seemed more chemically reasonable in the abstract.
The ring confirmed
The beta-lactam ring result has held without qualification since 1949: it is now textbook chemistry that penicillin, and the wider family of antibiotics built on the same skeleton, depend on this specific four-membered ring. That structural detail turned out to be directly connected to how the drug works — penicillin’s mechanism involves binding to proteins that build the bacterial cell wall and blocking the final cross-linking step, and the strained ring is central to that chemistry, so getting the structure right was not a side issue to understanding the antibiotic’s action but a precondition for it. Hodgkin’s broader crystallographic method also held up: it is the same approach, refined further, that gave her the vitamin B12 structure in the 1950s and the insulin structure in 1969, and that later became a standard tool of structural biology generally.
Structure is not mechanism
What the source material does not support is any claim that Hodgkin’s structural work explained why penicillin kills bacteria — that mechanism, involving binding to penicillin-binding proteins and blocking cell-wall synthesis, is described separately and was not the question her crystallography answered. It is also worth noting that resistance to penicillin, arising mainly through bacterial production of beta-lactamase enzymes that break the ring apart, is a later and distinct part of the story, not something the 1949 structure determination anticipated or addressed. Hodgkin settled what the molecule was shaped like; the material gives no basis for treating that settlement as also having settled how the drug acts on bacteria or how bacteria came to evade it.
From extraction to synthesis
Knowing penicillin’s exact structure mattered practically because it made deliberate synthesis and modification possible rather than leaving chemists dependent on extracting the compound from mould cultures. John Sheehan’s first full chemical synthesis, completed at MIT in 1957, followed from having a confirmed structure to synthesise toward, and the whole later family of semi-synthetic penicillins and related beta-lactam antibiotics depends on chemists knowing precisely which bonds and rings they are working with. More broadly, Hodgkin’s success in resolving a structure that had defeated argument from chemical intuition alone was an early demonstration of X-ray crystallography’s power for biological molecules — a method that went on to determine the structures of proteins and nucleic acids far more complex than penicillin, reshaping how biochemistry as a field established what molecules actually looked like.
A technique proving itself
This is a rewarding case study if the interest is in how a stubborn chemical disagreement gets resolved by direct measurement rather than further argument — chemists disputing a proposed ring structure for years, settled by one crystallographer’s diffraction data rather than by consensus. It is less useful as an account of antibiotic action or resistance, which the material treats as separate matters connected to but not explained by the structure itself. Read alongside Hodgkin’s later work on vitamin B12 and insulin, it also shows a scientist’s method maturing across a career, since the same crystallographic approach that took years to settle penicillin’s ring later cracked far larger molecules — making this as much a story about a technique proving itself as about one antibiotic.